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Abstract 
brain is the most complex human organ, consuming more energy than any other tissue in proportion to 
its size. It relies heavily on mitochondria to produce energy and is made up of mitotic and post mitotic 
cells that need to closely coordinate their metabolism to maintain essential bodily functions. During 
ageing, damaged mitochondria that produce less ATP and more Reactive Oxygen Species (ROS) 
accumulate. The current consensus is that ROS cause oxidative stress, damaging mitochondria, 
resulting in an energetic crisis that triggers neurodegenerative diseases and accelerates ageing. 
However, in model organisms increasing mitochondrial ROS (mtROS) in the brain extends lifespan, 
suggesting that ROS may participate in signalling that protects the brain. Here we summarize, the 
mechanisms by which mtROS are produced at the molecular level, how different brain cells and 
regions produce different amounts of mtROS and how mtROS levels change during ageing. Finally, 
we critically discuss the possible roles of ROS in ageing as signalling molecules and damaging agents 
addressing whether age associated increases in mtROS are a cause or a consequence of aging.  
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1. Introduction: The importance of the brain in the aging process 
 
 The ageing process leads to the indiscriminate loss of physiological functions across an 
organism. As the human population continues to live longer, many age associated diseases are 
becoming more prevalent, placing an ever growing burden on health and social systems. 
Understanding how and why we age is vital if we are to find ways to live better for longer. To do this 
we need to examine the organs and organelles which play key roles in physiology and the aging 
process.  
Many of our body’s physiological functions are set or controlled by our brains. The brain is 
the most complex organ in the human body. It is the centre of our nervous system and orchestrates 
many processes required for homeostasis and physical actions. The brain is made up of 3 distinct 
regions, the cerebrum, cerebellum and brain stem and broadly two cell types, neurons and glia. These 
cell types can further be divided into specific types of neuron and glial cells, each with a specific role 
and biology [1]. The brain holds our consciousness and the key to who we are, and as such is 
irreplaceable. It plays a central role in physiology and metabolism and may be at the centre of aging. 
Understanding how the human brain ages and identifying interventions to delay or reverse this 
process may be crucial for the delay or reversal of whole body healthy aging.  
To carry out its many autonomous and non-autonomous functions the brain is highly 
metabolically active, using nearly a quarter of the body’s total consumption of glucose and oxygen. 
This high level of oxygen consumption can lead to an increase in the production of Reactive Oxygen 
Species (ROS). As set out by the free radical and mitochondrial free radical theories of aging, 
increased levels of ROS and the resulting oxidative damage correlate highly with aging [2]. One of 
the major sources of ROS in the brain are mitochondria, referred to as mitochondrial ROS (mtROS). 
Mitochondria play a role in many important cellular functions including the production of ATP via 
oxidative phosphorylation which also produces ROS.  ROS, a collective title given to a whole host of 
reactive molecules, have for the most part been associated with negative effects, reviewed here [3]. 
However, in recent years the essential role of ROS in signalling has been uncovered[4]  
Alterations in mitochondria and mitochondrial function have long been considered hallmarks 
and potential drivers of aging [5]. In the aging brain, mitochondrial function is reduced while the 
number of damaged mitochondria and ROS accumulate [6]. This also correlates with increased levels 
of products of oxidative damage such as 8-OH-dG and mutation load in mtDNA [6]. The increase in 
oxidative damage to mtDNA, mitochondrial lipids and proteins correlates with the accumulation of 
less functional and damaged organelles [5]. Given that the accumulation of damaged mitochondria is 
a universal hallmark of aging, understanding this phenomenon is essential for anti-aging 
interventions. Moreover, it is also likely that the dysregulation of ROS production as a function of age 
is linked to this. 
In this review, we will explore the connection between mtROS, their role in brain physiology 
and aging. For the sake of space, we will focus on physiological aging of the brain i.e. that which 
occurs in the absence of diagnosed neurodegeneration.  We will examine the nature, site and level of 
mtROS production in regards to cellular signalling, oxidative stress, aging and the rate of aging. Most 
importantly we will examine how disruption of site and species specific ROS signalling vs non-
specific ROS produced from damaged mitochondria or elsewhere contributes to aging in the brain. 
This is particularly of interest given the failure of many antioxidant therapies to delay or reverse 
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aging, despite the age-related increased in oxidative damage and many examples were boosting 
mtROS does not have a negative impact on longevity [7, 8].   
2. How and where are ROS produced in the brain? 
 
2.1 Importance of detecting ROS in vivo to study ROS signalling.  
 
For a long time ROS were considered a single entity with the level of ROS considered the 
only factor important in determining their physiological effects. It was during this time that the 
Mitochondrial Free Radical Theory of Aging was the most widely accepted explanation for aging and 
antioxidant therapies were seen as the “Holy Grail” for lifespan extension. Nowadays however, it is 
well accepted that ROS are essential components of the cellular signalling machinery, playing 
essential roles in cellular differentiation and maintaining homeostasis [4]. Moreover, we know that 
each distinct ROS has different properties. Less reactive oxygen species (loROS), such as superoxide 
and particularly hydrogen peroxide, participate in cellular signalling whereas highly reactive oxygen 
species (hiROS), such as the hydroxyl radical or peroxynitrite, can damage all types of biological 
molecules resulting in oxidative damage [9].  
 
 There is increasing evidence that mtROS levels are strictly controlled at the levels of 
generation and neutralization[10]. Controlling mtROS at the point of generation implies regulation of 
the type of ROS and when, where and how much is produced. Similarly, controlling levels of mtROS 
via neutralization requires selection of an antioxidant system as well as knowledge of when and where 
to act. Strikingly, cells have only developed specific enzymatic systems to scavenge loROS e.g. 
superoxide dismutases (against superoxide), peroxiredoxins and glutathione peroxidases (against 
hydrogen peroxide). This suggests that hiROS most likely originate from loROS (e.g. by Fenton and 
Haber-Weiss reactions) and as such preventing their generation is more effective than developing 
pathways to effectively neutralize hiROS.  
  
 Until recently, ROS measurements carried out in isolated mitochondria were the preferred 
method to study ROS. The majority of studies using this approach have reported a negative 
correlation between extra-mitochondrial generation of hydrogen peroxide and lifespan (reviewed in 
[2]). Studies in isolated mitochondria, sub-mitochondrial particles or isolated complexes have many 
caveats (summarized in [8]), but one big advantage is the high resolution, allowing interrogation of 
where and how ROS are being generated. New tools and methods have been developed to study levels 
of superoxide, hydrogen peroxide, peroxynitrite etc. both ex vivo and in vivo (see [11]). This has 
allowed the measurement of ROS in more physiological conditions with the disadvantage that they 
lack the resolution of in vitro studies. As such, it is very difficult to determine exactly where and by 
which mechanisms ROS are generated. These are not the optimal conditions since studying the role of 
ROS in cellular signalling requires examining four different parameters: when, where, how much and 
which type of ROS is produced. 
 
 A way to increase resolution is to use specific inhibitors of the electron transport chain (ETC) 
in a similar way to in vitro studies. Although this approach is relatively easy to implement in cells in 
culture, it is much more difficult to deliver inhibitors at active concentrations in vivo. Alternatively, it 
is possible to manipulate the activity of the ETC using genetic manipulation via mutation, knock-
down of specific respiratory complex subunits that will prevent assembly of the respiratory complexes 
[12] or expression of alternative respiratory enzymes to regulate the redox state of the ETC [13]. For 
example, allotopic expression of an alternative oxidase (AOX) that reduces oxygen to water with 
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electrons from ubiquinol, allows the maintenance of the ETC in an oxidized state,  preventing electron 
leak and ROS production in fruit flies [14]. Conversely, it is possible to increase the redox state of the 
ETC by allotopically expressing alternative NADH dehydrogenase internal 1 (NDI1) that reduces 
ubiquinone to ubiquinol. This increases electron leak and ROS production in fruit flies [14]. Finally, 
novel antioxidant molecules that prevent electron leak from specific sites within the respiratory 
complexes have been developed and tested in human cells as well as mouse and fly models [15, 16]. 
S1QELs (suppressors of site IQ electron leak) prevent the generation of ROS by CI [16], whereas 
S3QELs (selective suppressors of site IIIQo electron leak) prevent the generation of ROS by CIII[15]. 
These molecules do not alter the function of the complex and therefore do not alter mitochondrial 
respiration and thus are extremely useful to study the role of ROS in signalling.  
  
2.2 Production of ROS at the molecular level: the mitochondrion. 
 
 There are up to 11 distinct sites where ROS can be produced in isolated mitochondria [17]. 
However, only three of these sites have been shown to be relevant for ROS production in vivo: 
respiratory complex I (CI aka NADH:ubiquinone oxidoreductase), complex II (CII aka succinate 
dehydrogenase) and complex III (CIII aka Ubiquinol:cytochrome c reductase) (Figure 1). 
Surprisingly, respiratory complex IV (CIV aka cytochrome c oxidase) which reduces oxygen to water 
does not produce any ROS, demonstrating that electron leak, and ROS production, can be prevented 
in the ETC.  ROS produced by CII are important for the development of certain types of cancer [18], 
while ROS produced by CI and CIII have been shown to regulate several physiological and 
pathological processes ranging from cellular differentiation to damage during ischemia/reperfusion [4, 
19]. Interestingly, the topology of ROS production for CI and CIII is different. All ROS produced by 
CI are directed to the mitochondrial matrix, whereas ROS produced by CIII are split between the 
intermembrane space and the matrix [20]. This distinction could be an important in determining why 
ROS produced at CI and III have different downstream effects.  
  
 ROS produced by CIII are required to trigger the hypoxia response and are instrumental in 
cellular differentiation of human adipocytes for example (reviewed in [21]). While ROS produced by 
CI are instrumental for the differentiation of myocytes to myotubes, oxygen sensing by cells of the 
carotid body, organization of the ETC, oxidative damage caused during ischemia-reperfusion, 
metabolic reprogramming of macrophages in response to bacterial infection and regulation of lifespan 
(reviewed in [8]). CI can produce ROS in both the forward and reverse direction. Interestingly, all 
these functions are performed when ROS are produced by reverse electron transport (RET)[8]. RET 
occurs when the pool of CoQ becomes over-reduced with electrons and the reduced form (ubiquinol) 
transfers electrons back to CI [22]. A role for RET-ROS signalling as a communication system 
between mitochondria and the rest of the cell is plausible as RET can provide information about how 
much ATP is being synthesized (since RET is influenced by changes in the proton motive force) and 
electron flow (as it is also sensitive to changes in the redox state of the CoQ pool). Indeed, through 
RET a significant amount of ROS are produced that can be used to transmit information.   
 
The fact that ROS produced by CI and CIII activate distinct and specific cellular processes 
supports the existence of ROS signalling specific to each complex. Both CI and CIII would be 
important generators of site-specific ROS. As we will discuss below, deregulation of ROS generation 
by CI and CIII as well as other as yet uncharacterized generators of site-specific ROS may be an 
important contributor to aging.  
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2.3 ROS Production at the molecular level: extra-mitochondrial sites. 
 
 mtROS are considered the key population of ROS involved in the aging process as it is 
assumed that they are continually generated as a result of mitochondrial respiration [23]. However, 
enzymes located out with the mitochondrion are also able to produce ROS. A non-exhaustive list 
includes, NADPH oxidases (NOXs), xanthine oxidase, monoamine oxidase and peroxisomal enzymes 
(Figure 1).  
 
 After the mitochondrial respiratory complexes, NOXs are probably the major enzyme group 
producing ROS. In fact, they are the only family of enzymes whose specific function is ROS 
production (either superoxide or hydrogen peroxide) [24].  NOXs  participate in various signalling 
pathways instrumental for the regulation of growth and inflammation, while their importance in aging 
and age-related diseases is supported by several studies [25].  There is a continuous “crosstalk” 
between NOXs and mtROS resulting in the modification of cellular ROS levels [26]. Other ROS 
generators such as xanthine oxidase (XO) [27, 28] or monoamino oxidase (MAO) [29], located in the 
outer membrane of the mitochondrion facing towards the cytosol, produce more ROS during aging. 
Increased ROS production by XO in the context of the aging brain is not clear, but increased ROS 
production by MAO has been linked with neuronal cell death in the substantia nigra [30].  
 
Finally, in addition to the mitochondria other organelles have to deal with significant amounts 
of ROS and how they do this influences the total ROS levels in the cell. As you would expect this has 
consequences for redox signalling and can trigger oxidative stress. The peroxisome is one of the most 
important generators and detoxifiers of hydrogen peroxide in the cell [31]. Accordingly, loss of redox 
homeostasis within peroxisomes correlates with increased levels of hydrogen peroxide and the 
induction of cellular senescence [32]. Lysosomes are instrumental for turnover of damaged proteins 
and organelles. However, the unintended release of lysosomal content such as free metals (e.g. iron) 
and free radicals can promote oxidative damage [33]. Age-related accumulation of undigested 
lysosomal material in the form of lipofuscin is considered the best biomarker of aging [33]. 
 
In this review, we will focus mainly on mtROS. However, it is important to keep in mind that 
there are other sites in the cell where ROS can be produced. Those referred to above are important as 
they can generate site-specific ROS, participating in signalling (e.g. NOXs), or unspecific ROS, 
increasing oxidative damage (e.g. lysosomes). As we will discuss, deregulation of the “crosstalk” 
between ROS generators could underlie the age-related increase in mtROS observed during aging.  
 
2.4 mtROS Production at the cellular level:  mtROS generation in Neurons vs Glia. 
 
 Mitochondria have diverse shapes, compositions and operate differently depending on how 
much ATP needs to be generated and which of its supplementary functions are required [34, 35]. For 
example, heart and liver mitochondria have distinct lipid and protein compositions [34, 36], and 
accordingly respire and produce ROS at different rates [36]. This is expected since heart mitochondria 
need to continually supply high levels of ATP to satisfy the high energetic demand of the heart.  Even 
within a cell, mitochondria can be diverse depending once again on the requirement of ATP and any 
additional functions. This is particularly true in highly polarized cells, such as neurons, where 
mitochondria develop specialized functions depending on the region of the cell in which they are 
located. For example, synaptic and non-synaptic mitochondria have different protein compositions, 
respiration rates and generate different amounts of ROS [37].   
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 Neurons and glia use different metabolic pathways to produce energy. Astrocytes are highly 
glycolytic, while neurons require oxidative phosphorylation.  Glucose is mainly consumed by glia that 
“feed” neurons with lactate and other small metabolites which are oxidized by neuronal mitochondria 
to obtain energy [38]. Given their metabolic differences, it is not surprising that neuronal and glial 
mitochondria produce different amounts of ROS. In a comprehensive study, Lopez-Fabuel and col. 
[39] demonstrated that in rats and mice CI specifically produces more ROS in glia than in neurons. 
Using an elegant combination of in vitro, ex vivo and in vivo approaches, the authors show that CI is 
incorporated less into respiratory supercomplexes as a result of a limitation of CIII in glia [39]. The 
increase of “free” CI in glia could explain why glia produces more ROS.  Interestingly, modulating 
the levels of a single CI subunit, NDUFS1, they were able to increase or decrease mtROS in neurons 
and glia. For example, overexpression of NDUFS1 in glia promoted incorporation of CI into 
supercomplexes, reducing ROS levels [39]. Conversely, knock down of NDUFS1 in neurons 
increased mitochondrial ROS production. In the future, it would be interesting to determine if there 
are differences in CI incorporation into supercomplexes between mitochondria within a cell (e.g. 
synaptic versus non-synaptic mitochondria) and the effect on the rate of ROS production.  
  
 Respiratory complexes are organized into super structures known as supercomplexes [40].  
Recent work has shown that the incorporation of respiratory complexes into supercomplexes is 
modified in response to changes in the proportion of different “fuels” or substrates that feed 
mitochondria (e.g. pyruvate, fatty acids, amino acids, etc) [41]. For example, CI is predominantly part 
of the so called “respirasome” (the super-structure made by CI in association with  CIII and CIV) 
when pyruvate is used to obtain energy in the mitochondria, whereas it is “released” from the 
respirasome when fatty acids are used as a substrate [41] or glucose is oxidized via anaerobic 
glycolysis to obtain energy [39]. Interestingly, both the levels of CI and its assembly into 
supercomplexes are determined by levels of ROS and specifically by ROS produced via RET at CI 
[42]. Both in vitro and ex vivo experiments support the idea that to reduce ROS generation CI must be 
incorporated into supercomplexes [39, 43, 44]. Disruption of mitochondrial supercomplexes would 
increase electron leak (and ROS production) and as a result the rate of aging [45]. In support of this 
idea, in aged rat brains supercomplexes are disorganized [46], which could explain why their 
mitochondria produce more ROS [47].  
 
2.5. ROS production in different regions of the brain.  
 
The brain is particularly sensitive to oxidative damage due to its high rate of oxygen 
consumption, the abundance of polyunsaturated fatty acids prone to oxidation and the increased 
concentration of transition metals such as iron or copper. Due to the heterogeneous nature of the brain 
which includes several cell and sub cell types certain areas of the brain are more sensitive than others 
to changes in oxidative stress [48] or levels of ROS [49]. It is important to highlight that ROS can 
cause reversible redox modifications (mainly in proteins e.g. reversible oxidation of specific 
cysteines) as well as irreversible oxidative damage, i.e. causing structural damage in biomolecules. 
Therefore neurons, and other cell types, can be more susceptible to changes in ROS levels because 
they are more sensitive to oxidative damage or less resilient to alterations in ROS signalling. 
Understanding how different cells, including different types of neurons and glia, respond to changes 
in ROS is instrumental for designing therapies that prevent oxidative stress without interrupting ROS 
signalling.  
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 Neurons and glia have diverse sizes, morphologies and metabolic features (see above). 
Despite producing fewer mtROS, neurons are more sensitive than glia to oxidative stress because they 
have fewer antioxidants [50]. In addition, we must keep in mind that neurons are post mitotic cells 
that are rarely replaced during the lifetime of the individual. This last feature makes neurons more 
sensitive to alterations in cellular homeostasis including changes in redox state. Different types of 
neurons also show differences in topology, myelination and the number of synaptic connections, all of 
which can alter their sensitivity to changes in ROS levels. This phenomenon is known as selective 
neuronal vulnerability [51]. In general, large neurons with long axons are more likely to die in 
response to increased oxidative stress [51]. Additionally, neurons which produce more ROS are those 
most sensitive to oxidative stress [52]. Some areas of the brain such as the hippocampus, substantia 
nigra, amygdala and frontal cortex are more sensitive to oxidative stress. Within these areas some 
neurons are more sensitive than others, i.e. CA1 neurons in the  hippocampus or neurons of pars 
compacta in the substantia nigra  [51]. In response to severe hypoglycaemia, ROS are most increased 
in hippocampus and striatum [53]. Coincidentally, these are the two areas that accumulate the highest 
level of protein carbonyls during aging [54]. The hippocampus is also the most sensitive area to 
damage due to ischemia-reperfusion [55] and where oxygen consumption is found to be most 
decreased during aging [56].  
 
 The existence of all this regional and cellular heterogeneity is an important reminder that 
ROS can result in neurodegeneration (or glial cell death) in certain areas of the brain but not in others. 
Similarly, certain areas or cells are affected by increases in oxidative stress whereas others will be 
damaged by alterations in redox signalling. Conversely, in certain areas the age-related increase in 
ROS could be a protective mechanism to stimulate activation of quality control systems via 
mitohormesis (see section 3), while in others an increase in unspecific ROS could cause oxidative 
damage. In fact, the heterogeneity of the brain, where certain areas are sensitive to ROS and others are 
protected by stimulation of redox signalling, could explain the failure of antioxidant strategies to 
extend lifespan or protect against age-related diseases [7].  
 
 
3. Mitochondrial ROS during aging. 
 
3.1 Damaged mitochondria that produce more ROS accumulate during aging. 
 
 Accumulation of damaged mitochondria is considered an universal hallmark of aging [5]. 
Mitochondria from brains of old individuals consume less oxygen and generate less ATP [57, 58]. 
Surprisingly, not all respiratory complexes are affected equally by aging. The activity of complex IV 
[57, 59] and the activity and levels of CI [14, 49, 60] have been reported by many studies to be 
reduced, whereas changes in the activity/levels of other respiratory complexes are inconsistent. The 
reduction in the activity of specific respiratory complexes or the alteration in the ratio between them 
will have important consequences on ROS levels. Reduction in complex IV activity would increase 
the redox state of the ETC, stimulating electron leak, ROS production and oxidative stress. On the 
other hand, reduction in the levels and activity of CI would reduce site-specific ROS signalling 
produced via CI (see section 2.2).  
  
 The accumulation of damaged mitochondria in the brain is usually explained as a 
consequence of the increased ROS production of brain mitochondria during aging [14, 47, 61, 62]. 
However, the opposite could be also true, that the increase in mtROS is in fact a consequence of the 
reduced activity of mitochondria. In fact, data from the “mutator” mouse do not support the usual 
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interpretation.  Due to a knock-in mutation in POLG (aka DNA polymerase subunit gamma in charge 
or replicating and repairing mitochondrial DNA) “mutator” mice accumulate mutations in their 
mtDNA at an accelerated rate [63]. This results in a strong progeria-like phenotype which includes a 
significant reduction in mitochondrial respiration [64]. However no increase in mtROS levels [64] or 
oxidative damage [65] is observed, which does not support the idea that reduction in mitochondrial 
electron flow increases ROS levels and oxidative damage. In this respect, the “mutator” mice are 
different to wild type mice where ROS levels [47, 61, 62, 66] in the brain increase in parallel with the 
accumulation of oxidized lipids[57], proteins[49, 67] and DNA [6, 68].  Therefore, it is also debatable 
if the “mutator mouse” is a good model of physiological aging.  
 
3.2 How can ROS cause damage and contribute to aging? Do ROS induce cell death or cellular 
senescence? 
 
ROS can cause damage through two different mechanisms (Figure 2). hiROS such as 
hydroxyl radicals or peroxynitrites can directly attack proteins, lipids and DNA [69]. loROS such as 
superoxide or hydrogen peroxide are able to produce highly reactive oxygen species when they react 
with transition metals through the Fenton’s and Haber-Weiss reactions.  For example, superoxide can 
attack iron-sulphur clusters synthetized in the mitochondria and present in many mitochondrial 
enzymes including aconitase, CI and CII. This causes the release of free iron and hydrogen peroxide 
leading to the production of hydroxyl radicals, oxidative damage and cell death [70]. Although 
antioxidants and repair systems are in place to prevent oxidative damage, the fact that oxidized 
molecules accumulate with age in the brain (see above) demonstrates that these systems are not 100% 
effective. Accordingly, levels of oxidative damage in the brain correlate with performance in different 
cognitive and activity tests in rodents [54] suggesting that this type of damage has an impact at a 
physiological level. Secondly, alterations in site-specific ROS signalling (caused by alterations in 
complex I and IV) can alter cellular responses affecting mechanisms of quality control or 
reprogramming cells in ways that make them more vulnerable to cell death [71], senescence [72] or 
induce their transformation into cancer cells [73]. Finally, both processes are probably interconnected 
since deregulation of ROS signalling triggers oxidative stress [74] and oxidative stress causes 
alterations in ROS signalling [75].  
 
 Neuronal death is considered the main driver of aging in the brain and the most important 
initiator of several neurodegenerative diseases [76]. Historically glia have not received the same 
attention as neurons, recently however it has become evident that they are as important, if not more, 
as neurons in the aging process [77]. A recent study demonstrated that changes in glia specific genes 
are more pronounced than changes in neuron specific genes during aging [78], indicating the 
importance of genomic alterations in glia.  Interestingly, changes in gene expression were higher in 
areas such as the hippocampus and substantia nigra, with higher levels of ROS and oxidative damage 
as we have discussed previously (section 2.5).  Cell death can be caused by mitochondrial dysfunction 
due to a severe reduction in ATP production or the release of pro-apoptotic factors such as 
cytochrome c or AIF (Apoptosis Inducing Factor) [79] . Similarly high levels of mtROS can cause 
cell death via apoptosis or necrosis [80]. In addition to directly promoting cell death in neurons and 
glia, the age related increase in mtROS promotes neuroinflammation, which can cause 
neurodegeneration [81]. In this case, the age related increase in mtROS in microglia will cause the 
secretion of pro-inflammatory cytokines promoting neurodegeneration [81].  
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 Other than inducing cell death mtROS can induce a permanent cell-cycle arrest known as 
cellular senescence. Senescent cells are characterized by the secretion of pro-inflammatory factors 
that contribute to the transformation or induction of senescence in neighbouring cells  [82]. mtROS 
are instrumental for the initiation and maintenance of cellular senescence [83, 84]. Maintenance of 
senescence is achieved via a positive feedback loop where mtROS causes DNA damage (in the 
nuclear DNA) and activation of CDK1N1 (p21). Subsequently, p21 induces mitochondrial 
dysfunction and more ROS that are required to maintain DNA damage and senescence [84]. The 
existence of such a mechanism indicates that mtROS act as redox messengers and not by 
indiscriminately increasing oxidative damage. Cellular senescence has been considered a mechanism 
which affects only mitotic cells and therefore would be restricted to glia in the brain. However, a 
recent pioneering study showed that neurons can also display a senescence-like phenotype that is 
dependent on p21 and levels of mtROS [72]. Interestingly, the areas of the brain with higher levels of 
ROS, such as the hippocampus, are also the areas with an increased presence of neurons presenting a 
senescence-like phenotype [72]. If the existence and importance of senescence cells in the brain is 
further confirmed, the existence of senolytic drugs that have been shown effective to correct age-
related alterations in other organs such as the liver [85] or lung [86] could also be effective in the 
brain and improve memory or coordination of aged individuals. 
 
3.3 How do ROS increased during ageing?  
 
 The “vicious cycle” hypothesis explains the increase in mtROS observed during aging as a 
consequence of a negative feedback mechanism where mtROS cause the accumulation of mutations in 
mtDNA (Figure 3A). Mutations in ETC subunits will result in the assembly of defective respiratory 
complexes that will produce more ROS [87].  Although, this hypothesis has a strong internal logic, it 
is not fully supported by experimental data. Firstly, mutations found in old individuals (particularly 
deletions) are more likely caused by errors produced during replication or repair of the mitochondrial 
DNA than directly by the action of free radicals [88, 89]. Secondly, inducing mutations in 
mitochondrial DNA does not increase ROS levels in isolated mitochondria [64], although a recent 
publication measuring mtROS levels in vivo found higher levels of ROS in old “mutator” mice when 
compared to controls [90].  The fact that no differences in ROS were found between young “mutator” 
mice and controls discards the hypothesis that mutations per se are responsible for increased ROS, 
since young mice already carry more mutations in their mitochondrial DNA than old wild type mice 
[91]. Finally, interruption of electron flow in mice through mutation of COQ7, an essential gene for 
the synthesis of CoQ, causes the accumulation of respiratory deficient mitochondria, a progeria-like 
phenotype and shortens lifespan without increasing ROS levels in isolated mitochondria [92], 
demonstrating in a different model that interruption of electron flow does not necessarily increase 
electron leak. 
 
 Damaged mitochondria, whole organelles or components, are turned over with the help of 
quality control mechanisms like autophagy and the proteasome. The age-associated reduction in the 
efficiency of both mechanisms [5] might explain the accumulation of respiratory-deficient 
mitochondria during aging (Figure 3B). Supporting this hypothesis, boosting autophagy or increasing 
the activity of the proteasome extends lifespan in model organisms, including mouse models [93-96]. 
Moreover, specifically boosting mitophagy i.e. the specialized autophagy process that recycles 
damaged mitochondria, is enough to extend lifespan in worms and flies [97, 98]. Although these 
results do not prove that damaged mitochondria per se are responsible for aging (see also below), they 
strongly suggest that maintaining a healthy population of mitochondria in aged individuals is 
important to guarantee healthy lifespan. Damaged mitochondria that produce higher levels of ROS 
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can contribute to the collapse of quality control mechanisms in old individuals. Different reports have 
shown that the efficiency of cellular quality control is regulated by redox changes in key components 
such as the 20S proteasome [99] or the cysteine protease ATG4 [100].  Very high levels of ROS can 
cause irreversible oxidation of cysteine residues that are redox regulated impeding the proteins 
carrying them from executing their normal function. Although published reports are contradictory 
about whether ROS stimulate or inhibit quality control mechanisms (summarized in [101, 102]), 
redox regulated control via site-specific ROS signalling would involve specific ROS (e.g. hydrogen 
peroxide) produced in specific places and amounts. Conversely, damaged mitochondria could 
generate incorrect signals i.e. the wrong ROS produced at the wrong time/place will prevent the 
correct function of quality control.  If this mechanism is true, the question to answer is why 
mechanisms of quality control fail in the first place and the answer is probably in the genome. 
  
 Since all the information required for making the cell work, and by extension the whole 
organism, is encoded in the DNA, it is worth looking at how age-related changes in the genome and 
epigenome affect mitochondria.  Recent publications have shown that changes in mitochondrial 
function are instrumental for cellular differentiation [103]. For example, neuronal differentiation 
requires a switch from glycolysis to oxidative phosphorylation [104]. Conversely, cellular 
reprograming of mouse embryonic fibroblasts into pluripotent cells requires repression of oxidative 
phosphorylation and activation of glycolysis [105]. As we mentioned previously, mitochondrial 
morphology and composition depends on the amount of ATP and accessory functions mitochondria 
are required to perform (section 2.4). These characteristics determine how much the mitochondria 
respire and how many ROS are generated.  A very clear example of this is the obvious differences 
between mitochondria in differentiated and undifferentiated cells. Pluripotent cells have mitochondria 
with lower rates of respiration, fewer cristae and a rounder morphology [106] when compared to 
differentiated cells. In parallel with increased oxidative phosphorylation, cell differentiation occurs 
after a boost in ROS levels [107]. As mentioned previously the information to build both types of 
mitochondria is encoded in the genome. Aging is characterized by the accumulation of genetic and 
epigenetic changes that affect both the information encoded in the DNA as well as how this 
information is interpreted, i.e. how is transcribed and translated [5]. Therefore it is plausible that 
genetic and epigenetic changes occurring during aging will impact on the nature of the mitochondria 
present in aged tissues. This could result in the presence of mitochondria that are not “suited” to 
perform the specific tasks required in a particular cell or location. These “misplaced” mitochondria 
could generate more ROS in order to activate their own turnover since the mitochondria have 
mechanisms to sense dysfunction (e.g. RET [19]). Chronically high levels of ROS could potentially 
trigger oxidative stress and contribute to the saturation of quality control mechanisms, which would 
spread the damage [33]. 
  
  Although, the above explanation is only hypothetical, there is preliminary data suggesting 
that age-related genomic/epigenomic dysfunction could be important in explaining age-related 
mitochondrial dysfunction warranting further investigation in the future (Figure 3C). Mutations in 
proteins involved in DNA repair or maintenance cause DNA damage, underlie progeria and have a 
strong effect on mitochondrial function [108]. Chronic DNA damage, due to defective DNA repair, 
causes over-activation of repair systems such as PARP or SIRT1 that use NAD+ as a cofactor causing 
its depletion at the cellular level [109]. Depletion of NAD+ has important metabolic consequences 
including suppression of mitophagy and the accumulation of damaged mitochondria that produce 
more ROS [109]. Interestingly, depletion in NAD+ levels has been observed during normal aging 
[110], whereas supplementing NAD+ or boosting its endogenous synthesis increases mitochondrial 
function and protects against progeria syndromes as well as physiological aging in worms, flies and 
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mice [111-113]. Based on the previously described experimental evidence, it is possible that age-
related increases in DNA damage [72, 83] activate mechanisms of repair that use NAD+ as cofactor 
causing its depletion. This could be partially responsible for the increase in damaged mitochondria 
that produce more ROS.  
  
 Another alternative to the “classical vicious cycle” hypothesis is that the increase in 
mitochondrial ROS is caused by a “ROS induce ROS” mechanism [26] due to increase in ROS 
produced elsewhere (Figure 3D). Several papers have described the connection between different 
ROS generators [114]. Particularly significant is the connection between NOXs enzymes and mtROS 
levels that seems to work in both directions. For example, starvation induces production of mtROS in 
human 293T cells activating the generation of ROS by NOX1 and cell death if prolonged [115]. 
Interestingly, mitochondrial ROS are insufficient to cause cell death and requires activation of NOX1 
[115]. Conversely, hypoxia induces activation of NOX2 which inhibits CI and increases mtROS in rat 
pheochromocytoma-12 cells (PC12) [116]. You would expect that there is coordination between 
specific ROS generators that are part of ROS signalling to make it efficient. For example, if all ROS 
generators produce ROS simultaneously the background (noise) would be so high that it would 
prevent the detection of a specific ROS signal. We can speculate that during aging there is an increase 
in unspecific ROS and a replacement of loROS (such as hydrogen peroxide) with hiROS (such as 
hydroxyl radical). These changes would “force” site-specific ROS generators in the mitochondria to 
increase the intensity of the signal establishing a negative cycle that would result in more and more 
ROS over time. Therefore one of the caveats of using ROS as a signalling system would be the need 
to increase the intensity of the signal during aging as a result of the accumulation of other types of 
damage (e.g. epigenetic alterations). Increasing the intensity of the signal would increase the noise 
and the possibility of triggering oxidative damage.  
   
 In summary, the increase in mtROS observed during aging could either be ROS produced as 
by-products (i.e. the wrong type or amount or produced at the wrong place/time) or a cellular response 
to the loss of cellular homeostasis associated with aging. In order to find effective anti-aging therapies 
it is imperative that we understand the exact nature of the ROS (which type, where, when and in 
which amount) as well as in which cell types and brain regions intervention is required.  
 
4. Conclusions. 
 
4.1 Are increased levels of mtROS a cause or a consequence of aging? 
 
As we have seen, COQ7mutations in mice cause a decrease in mitochondrial respiration and 
strongly reduce lifespan without increasing mtROS levels [92]. Interestingly, the defect in CoQ 
synthesis can be rescued by feeding of 4-dihydroxybenzoic acid (2,4-DHB) that bypasses the CoQ 
synthesis defect and restores mitochondrial respiration.  Surprisingly, administration of 2,4-DHB to 
mutant mice, just before controls fed with the placebo begin to die, was sufficient to restore lifespan 
[92]. This result is enormously surprising and indicates that the effects of carrying respiratory-
deficient mitochondria for more than 1/3 the lifespan in a mouse can be reversed. These results 
contradict the mitochondrial theory of aging [117] that postulates that loss of mitochondrial function 
is caused by mutations in mtDNA and independent of ROS levels causes aging. These data indicate 
that mitochondrial dysfunction is probably more a cause than a consequence of aging. These 
experiments require replication in other mitochondrial mutants and model organisms but indicate that 
preventing the accumulation of damaged mitochondria may not be enough to extend lifespan if other 
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hallmarks of aging (e.g. epigenetic changes or maintenance of quality control mechanisms) are not 
also targeted. Of course, and since mitochondria from COQ7 mutant mice do not produce more ROS 
it could be argued that higher levels of mtROS generation are required to cause irreversible damage. 
 
In fact, we have cited many reports demonstrating an increase in mtROS and an 
accompanying accumulation of oxidative damage in the brain of old individuals (section 3.1). 
However, it remains to be elucidated whether this is a cause or consequence of aging. Data in lower 
organisms do not support that increasing ROS accelerates aging. In fact many different reports mainly 
in worms and flies show that boosting ROS levels can in fact extend lifespan [8].  This phenomenon 
has been explained as a specific type of hormesis, called mitohormesis [118]. Inducing low or 
moderate levels of oxidative stress would activate repair and protective mechanisms that long-term 
can decrease oxidative stress [119]. However, it is not clear if long-term reduction of ROS is required 
for lifespan extension. For example, overexpression or feeding of antioxidants prevents the positive 
effect of mitohormesis on lifespan [14, 120, 121]. Moreover, overexpression or feeding of 
antioxidants, without boosting ROS do not extend lifespan [7]. These results do not support a major 
role of antioxidant systems in the lifespan extension conferred by mitohormesis, but other repair or 
protective systems such as autophagy and the proteasome cannot be discarded. ROS can become 
problematic in old individuals due to the failure in quality control mechanisms that occur during aging 
[5]. In this context, mtROS could trigger oxidative damage and/or alter redox signalling. From this 
point of  view, the increase in mtROS would initially be a consequence of aging later becoming an 
important contributor to its progression and may be the cause of the onset of age-related diseases 
including neurodegenerative diseases such as Parkinson’s or Alzheimer’s. 
 
4.2 Conclusions: summary. 
 
In summary, available results indicate that high levels of mtROS per se are not likely to be 
the proximal cause of aging, although in combination with other factors (e.g. epigenetic alterations or 
reduction in quality control systems) can be important for regulating the aging rate and the onset of 
age-related diseases including neurodegenerative diseases such as Parkinson’s. On the other hand, the 
increase in mtROS could be a signal for the activation of protection mechanisms in middle age. The 
continuous use of this strategy could cause oxidative stress in later life. Although a consequence and 
not a cause of aging, this oxidative stress would be still an important contributor to the development 
of neurodegenerative disorders such as Alzheimer’s or Parkinson’s disease, decreasing the quality of 
life and shortening healthy aging. 
 
 The present consensus states that low levels of ROS are beneficial, participating in cellular 
signalling and contributing to homeostasis, while higher levels are deleterious, causing oxidative 
damage. It is also currently accepted that accumulation of defective mitochondria during ageing is a 
consequence of increased oxidative stress. Unfortunately, this model does not explain a lot of the 
published observations, for example the failure of antioxidant therapies to attenuate ageing or that 
increasing ROS levels can extend lifespan. We propose an alternative model in which specific 
generators of ROS, such as the mitochondrial site-specific ROS generators CI and III, operate in a 
coordinated manner to fine tune metabolism and maintain cellular homeostasis in young individuals 
via redox signalling. During ageing, these signalling pathways, like many others, would be 
dysregulated resulting in production of unspecific ROS causing oxidative stress. If this model is 
correct, it is vital we understand how site-specific ROS signalling fails during ageing in order to 
identify and implement strategies that preserve this signalling and mitochondrial function, extending 
lifespan.  
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Figure Legends 
Figure 1. Generators of specific ROS involved in redox signalling. This schematic highlights the 
sources of ROS involved in redox signalling and their location in the cell.  At the cell membrane, we 
find NADPH oxidases able to produce superoxide (O2
.-
) and hydrogen peroxide (H2O2). The 
peroxisomes and mitochondria are also sites of significant ROS production. Xanthine Oxidase (XO) is 
located in the cytosol, while Monoamino oxidase (MAO) is located in the mitochondrial outer 
membrane. Thick arrows highlight the intracellular signalling that specific ROS carry out in order to 
maintain redox homeostasis which may be lost in ageing. Thin arrows describe the crosstalk between 
ROS producers and the nucleus in order to regulate redox signalling outputs.  
Figure 2. Mechanisms by which ROS can cause damage.  As the balance between and levels of 
more and less reactive ROS are altered in the aging brain, redox signalling is disrupted leading to 
transformation, senescence and cell death due to a failure to maintain redox homeostasis and 
increased oxidative damage. This leads to further dysregulation, amplifying the production of ROS 
from specific and unspecific sources. 
Figure 3. Alternative explanations for age associated increases in ROS and potential anti-ageing 
strategies.  The amplification of mtROS with age could be a result of a vicious cycle where ROS 
produced by the ETC leads to mutations in mtDNA which result in an ETC which produces higher 
levels of ROS (red stars indicate presence of mutated ETC subunits).  Strategies to combat this 
include the use of antioxidants which can quench ROS before they can induce damage or of new 
molecules (such as S1QELS and S3QELS) that specifically prevent electron leak at CI or CIII (A). On 
the other hand, with age the failure or declining efficiency of quality control mechanisms could lead 
to the lack of or improper clearance of damaged organelles resulting in the accumulation of damaged 
mitochondria producing increased amounts of ROS as well as the release of reactive metals into the 
cytosol. This could be counteracted via an enhancement in autophagic clearance of these 
mitochondria (B). At the DNA level, accumulation of mutations could lead to altered gene expression 
via changes to the genome and epigenome. The accompanying cellular imbalance could result in 
inhibition of mitophagy due to the excessive consumption of NAD+ in DNA repair processes. 
Strategies which prevent DNA damage or boost NAD+ levels would alleviate the accumulation of 
defective mitochondria (C).  Finally, ROS could drive the production of more ROS from sites of 
unspecific ROS production leading to an increase in the level of site-specific ROS production in order 
to increase signal intensity. Strategies which repress production of non-signaling ROS while 
concomitantly increasing the production of signaling ROS has the potential to maintain redox 
homeostasis and preserve cellular function (D).  
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